Publications by authors named "Nathan Vidal"

Claim this Profile
A
Anticholinergic burden as a precipitating factor for delirium spectrum disorders in schizophrenia spectrum and bipolar disorders: A case-crossover study based on the French nationwide claims database.
Nathan Vidal, Solène Frileux, Christine Passerieux, Nadia Younès, Eric Brunet-Gouet

J Psychiatr Res· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Flowers for Algernon: How metacognition affects quality of life in schizophrenia. Structural equation modeling with the FACE-SZ cohort.
Solène Frileux, Nathan Faivre, Mathieu Urbach, Nathan Vidal, Hugo Bottemanne

Compr Psychiatry· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neural network analysis of the contribution of psychotropic prescription sequences to the risk of non-psychiatric adverse events in bipolar and schizophrenia spectrum disorders.
Nathan Vidal, Mohammed Sedki, Nadia Younès, Hugo Bottemanne, Paul Roux

Front Digit Health· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exploring the Association Between Residual Mood Symptoms and Self-Reported Side Effects in the Euthymic Phase of Bipolar Disorders: A Cross-Sectional Network Analysis.
Nathan Vidal, Eric Brunet-Gouet, Solène Frileux, Valérie Aubin, Raoul Belzeaux

Depress Anxiety· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparative analysis of anticholinergic burden scales to explain iatrogenic cognitive impairment in schizophrenia: results from the multicenter FACE-SZ cohort.
Nathan Vidal, Paul Roux, Mathieu Urbach, Cristobal Belmonte, Laurent Boyer

Front Pharmacol· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis